IP Library Granted Patent US 10,633,681
Granted Patent B2
US 10,633,681 · App. 15/881,197 · Granted Apr 28, 2020

Apparatus and methods for biosynthetic production of cannabinoids

Inventors: Robert Winnicki (Cambridge, MA); Marc Donsky (Denver, CO); Mingyang Sun (Dublin, IE); Richard Peet (Washington, DC)
Assignee: Teewinot Technologies Limited
C12P17/06C07C29/80C07C37/01C07C37/74C12M21/18C12M29/00C12M29/04C12M41/12C12M41/26C12M41/30C12M41/32C12M41/40C12M41/48C12M47/10C12N9/0004C12P7/22C12P7/42C12Y121/03C12Y121/03007C12Y121/03008
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,633,681
App. No.
15/881,197
Granted
Apr 28, 2020
Kind
B2
Abstract

The present invention provides an apparatus and methods for producing tetrahydrocannabinolic acid (THCA), cannabichromenic acid (CBCA) and cannabichromenic acid (CBCA) in different ratios. The apparatus comprises: (i) a bioreactor comprising (a) an automated supply system configured to deliver a first automated supply of cannabigerolic acid (CBGA), a cannabinoid acid synthase, and a reaction mixture; and (b) a second automated system to cease the reaction; (ii) a controller configured to modify a property of the reaction mixture to produce the desired products; and (iii) an extractor configured to recover the tetrahydrocannabinolic acid (THCA), cannabichromenic acid (CBCA) or cannabidiolic acid (CBDA) and cannabichromenic acid.

Claims (34)

1. A method for producing cannabinoid products comprising:

(1) reacting a CBDA synthase in a reaction mixture with a compound according to Formula I:

wherein R 1 is H or —COOH and R 2 is a linear or branched CH 3 , C 2 H 5 , C 3 H 7 , C 4 H 9 , C 5 H 11 , C 6 H 13 , C 7 H 15 , or C 8 H 17 group;

(2) modifying one or more reaction conditions to modulate the ratio of the cannabinoid products; and

(3) recovering the cannabinoid products;

wherein the condition modified is pH or solvent.

2. The method of claim 1 , further comprising producing the CBDA synthase.

3. The method of claim 2 , wherein the CBDA synthase is a recombinant synthase.

4. The method of claim 2 , wherein the CBDA synthase is encoded by a nucleic acid sequence of SEQ ID NO: 5, SEQ ID NO: 7, or a variant or fragment thereof.

5. The method of claim 2 , wherein the CBDA synthase comprises a polypeptide of SEQ ID NO: 6, SEQ ID NO: 8, or a variant or fragment thereof.

6. The method of claim 2 , wherein the CBDA synthase is encoded by a cannabinoid acid synthase gene that is codon optimized with an alpha secretion sequence.

7. The method of claim 1 , wherein the pH in the reaction mixture is in the range from about 4.2 to about 6.2.

8. The method of claim 1 , wherein the reaction mixture comprises a solvent that comprises dimethyl sulfoxide (DMSO), dimethyl formamide (DMF), iso-propoyl alcohol, or combination thereof.

9. The method of claim 8 , wherein the solvent comprises DMSO.

10. The method of claim 8 , the concentration of the solvent in the reaction mixture is between 5% and 30% (w/v).

11. The method of claim 1 , wherein the CBDA synthase comprises a polypeptide of SEQ ID NO: 6, SEQ ID NO: 8, or a variant or fragment thereof.

12. The method of claim 2 , wherein the CBDA synthase is encoded by a cannabinoid acid synthase gene that is tagged with six tandem histidine residues (SEQ ID NO: 9).

13. A method for producing cannabinoid products comprising:

(1) reacting a THCA synthase in a reaction mixture with a compound according to Formula I:

wherein R 1 is H or —COOH and R 2 is a linear or branched CH 3 , C 2 H 5 , C 3 H 7 , C 4 H 9 , C 5 H 11 , C 6 H 13 , C 7 H 15 , or C 8 H 17 group;

(2) modifying one or more reaction conditions to modulate the ratio of the cannabinoid products; and

(3) recovering the cannabinoid products;

wherein the condition modified is pH or solvent.

14. The method of claim 13 , further comprising producing the THCA synthase.

15. The method of claim 14 , wherein the THCA synthase is a recombinant synthase.

16. The method of claim 14 , wherein the THCA synthase is encoded by a nucleic acid sequence of SEQ ID NO: 1, SEQ ID NO: 3, or a variant or fragment thereof.

17. The method of claim 14 , wherein the wherein the THCA synthase comprises a polypeptide of SEQ ID NO: 2, SEQ ID NO: 4, or a variant or fragment thereof.

18. The method of claim 14 , wherein the THCA synthase is encoded by a cannabinoid acid synthase gene that is codon optimized with an alpha secretion sequence.

19. The method of claim 13 , wherein the pH in the reaction mixture is in the range from about 3.8 to about 7.2.

20. The method of claim 13 , wherein the reaction mixture comprises a solvent that comprises dimethyl sulfoxide (DMSO), dimethyl formamide (DMF), iso-propoyl alcohol, or combination thereof.

21. The method of claim 20 , wherein the solvent comprises DMSO.

22. The method of claim 20 , the concentration of the solvent in the reaction mixture is between 5% and 30% (w/v).

23. The method of claim 13 , wherein the wherein the THCA synthase comprises a polypeptide of SEQ ID NO: 2, SEQ ID NO: 4, or a variant or fragment thereof.

24. The method of claim 14 , wherein the THCA synthase is encoded by a cannabinoid acid synthase gene that is tagged with six tandem histidine residues (SEQ ID NO: 9).

Assignments (5)
SECURITY INTEREST Recorded Nov 23, 2021
From: TEEWINOT TECHNOLOGIES LIMITED
To: TUATARA CAPITAL FUND I, L.P.; TUATARA CAPITAL PARALLEL FUND I, L.P.
Reel/Frame 058194/0448 →
SECURITY INTEREST Recorded Nov 23, 2021
From: TEEWINOT LIFE SCIENCES CORPORATION; TEEWINOT TECHNOLOGIES LIMITED
To: TUATARA CAPITAL FUND I, L.P.; TUATARA CAPITAL PARALLEL FUND I, L.P.
Reel/Frame 058194/0474 →
SECURITY INTEREST Recorded Nov 22, 2021
From: TEEWINOT TECHNOLOGIES LIMITED
To: TUATARA CAPITAL FUND I, L.P.; TUATARA CAPITAL PARALLEL FUND I, L.P.
Reel/Frame 058180/0377 →
SECURITY INTEREST Recorded Nov 22, 2021
From: TEEWINOT LIFE SCIENCES CORPORATION; TEEWINOT TECHNOLOGIES LIMITED
To: TUATARA CAPITAL FUND I, L.P.; TUATARA CAPITAL PARALLEL FUND I, L.P.
Reel/Frame 058182/0033 →
SECURITY INTEREST Recorded Aug 24, 2020
From: TEEWINOT TECHNOLOGIES, LTD.
To: TUATARA CAPITAL FUND I, L.P.
Reel/Frame 053582/0897 →
Continuity (6)
Continuation 15433270 · Feb 15, 2017
Continuation 15232405 · Aug 9, 2016
Continuation 15158565 · May 18, 2016
Continuation 14835444 · Aug 25, 2015
Provisional Application 62041521 · Aug 25, 2014
Related Publication 20180179564A1 · Jun 28, 2018